Safety and benefits of automated red cell depletion-exchange compared to standard exchange in patients with sickle cell disease undergoing chronic transfusion.
Yonah C ZiembaCindy XuKatayoun M FomaniVijay NandiTiejun YuanShiraz RehmaniBruce S SachaisAbena O Appiah-KubiBanu AygunJames E LouiePatricia A ShiPublished in: Transfusion (2020)
Our study supports that IHD-RCE can be safely used in patients with stroke risk and compared to standard RCE, results in benefits of lower RBC usage and/or fraction of cells remaining and higher postprocedure Hct associated with higher preprocedure Hct. These findings support wider use of IHD-RCE, especially in the current environment with reduced availability of minority units.